Chartwell Investment Partners LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 80.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 907 shares of the medical equipment provider’s stock after selling 3,793 shares during the period. Chartwell Investment Partners LLC’s holdings in Intuitive Surgical were worth $695,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of ISRG. Acropolis Investment Management LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at about $115,000. Huntington National Bank raised its position in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the period. Bessemer Group Inc. raised its position in shares of Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 96 shares during the period. Trillium Asset Management LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at about $207,000. Finally, Cambridge Advisors Inc. purchased a new position in shares of Intuitive Surgical during the first quarter valued at about $209,000. 97.56% of the stock is currently owned by institutional investors.
Intuitive Surgical, Inc. (ISRG) traded up 0.33% on Tuesday, hitting $939.45. The company had a trading volume of 156,699 shares. The stock’s 50-day moving average price is $885.92 and its 200 day moving average price is $755.57. Intuitive Surgical, Inc. has a one year low of $610.71 and a one year high of $948.98. The company has a market capitalization of $34.61 billion, a P/E ratio of 47.36 and a beta of 0.41.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $5.09 earnings per share for the quarter, topping analysts’ consensus estimates of $3.97 by $1.12. Intuitive Surgical had a return on equity of 15.41% and a net margin of 27.99%. The business had revenue of $674.20 million for the quarter, compared to the consensus estimate of $664.72 million. During the same period in the prior year, the business earned $4.42 EPS. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post $23.64 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thestockobserver.com/2017/06/20/intuitive-surgical-inc-isrg-stake-cut-by-chartwell-investment-partners-llc.html.
Several equities analysts have recently issued reports on ISRG shares. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research note on Monday, April 24th. Canaccord Genuity reaffirmed a “buy” rating and set a $800.00 price target on shares of Intuitive Surgical in a research note on Friday, March 24th. Barclays PLC reaffirmed a “buy” rating and set a $800.00 price target on shares of Intuitive Surgical in a research note on Sunday, March 26th. Wedbush upped their price target on Intuitive Surgical from $835.00 to $875.00 and gave the company an “outperform” rating in a research note on Monday, April 24th. Finally, Morgan Stanley set a $950.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, May 22nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $856.69.
In related news, VP Jamie Samath sold 490 shares of the company’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $811.67, for a total transaction of $397,718.30. Following the transaction, the vice president now directly owns 48 shares of the company’s stock, valued at approximately $38,960.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $887.09, for a total value of $2,661,270.00. Following the transaction, the senior vice president now directly owns 3,046 shares in the company, valued at $2,702,076.14. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,306 shares of company stock worth $46,588,332. 2.50% of the stock is owned by company insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.